NCT02480465 - Efficacy and Safety of Lobeglitazone Versus Sitagliptin | Biotech Hunter

Enrollment

248

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

March 31, 2017

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Lobelitazone 0.5mg

Lobelitazone 0.5mg, placebo of Sitagliptin 100mg, orally, 2 tablet once a day for 24 weeks with metformin

DRUG

Sitagliptin 100mg

placebo of Lobelitazone 0.5mg, Sitagliptin 100mg, orally, 2 tablet once a day for 24 weeks with metformin

Trial Locations (1)

RECRUITING

Korea University Anam Hospital, Seoul